PubMed:26215578 / 134-268
Annnotations
c_corpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T20 | 4-20 | UBERON:0000021 | denotes | epidermal growth |
| T23 | 4-27 | Q9GU69 | denotes | epidermal growth factor |
| T21 | 4-27 | D004815 | denotes | epidermal growth factor |
| T22 | 4-27 | D004815 | denotes | epidermal growth factor |
| T24 | 4-27 | GO:0005154 | denotes | epidermal growth factor |
| T30 | 29-32 | Q95ND4 | denotes | EGF |
| T32 | 29-32 | PR:P01133 | denotes | EGF |
| T33 | 29-32 | P01133 | denotes | EGF |
| T34 | 29-32 | PR:P07522 | denotes | EGF |
| T35 | 29-32 | PR:P01132 | denotes | EGF |
| T36 | 29-32 | Q9BEA0 | denotes | EGF |
| T37 | 29-32 | P01132 | denotes | EGF |
| T38 | 29-32 | P07522 | denotes | EGF |
| T40 | 29-32 | PR:000006928 | denotes | EGF |
| T41 | 29-32 | P26224 | denotes | EGF |
| T43 | 29-32 | Q00968 | denotes | EGF |
| T31 | 29-32 | CHEBI:140739 | denotes | EGF |
| T42 | 29-32 | D004815 | denotes | EGF |
| T44 | 29-32 | D004815 | denotes | EGF |
| T39 | 29-32 | GO:0005154 | denotes | EGF |
| T45 | 44-51 | CHEBI:52214 | denotes | ligands |
| T46 | 85-91 | UBERON:0000310 | denotes | breast |
| T47 | 85-98 | D001943 | denotes | breast cancer |
| T48 | 85-98 | D001943 | denotes | breast cancer |
UseCases_ArguminSci_Discourse
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 0-134 | DRI_Outcome | denotes | The epidermal growth factor (EGF) family of ligands has been implicated in promoting breast cancer initiation, growth and progression. |